Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent J Cunningham

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2012
Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptorChristine A Parker, Roger N Gunn, Eugenii A Rabiner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methodsAna M Catafau, Monica Danus, Santiago Bullich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2015
Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer DiseaseChristine A Parker, Eugenii A Rabiner, Roger N Gunn, et al.
Neuroimage|May 22, 2014
Acute increases in synaptic GABA detectable in the living human brain: a [¹¹C]Ro15-4513 PET studyPaul R A Stokes, Jim F Myers, Nicola J Kalk, et al.
European Radiology|April 6, 2012
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trialsEric O Aboagye, Fiona J Gilbert, Ian N Fleming, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancySergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2012
Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptorChristine A Parker, Roger N Gunn, Eugenii A Rabiner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methodsAna M Catafau, Monica Danus, Santiago Bullich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2015
Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer DiseaseChristine A Parker, Eugenii A Rabiner, Roger N Gunn, et al.
Neuroimage|May 22, 2014
Acute increases in synaptic GABA detectable in the living human brain: a [¹¹C]Ro15-4513 PET studyPaul R A Stokes, Jim F Myers, Nicola J Kalk, et al.
European Radiology|April 6, 2012
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trialsEric O Aboagye, Fiona J Gilbert, Ian N Fleming, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancySergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Pageof 4